GlobeNewswire

TOMI Environmental Solutions, Inc. Implements SteraMist Into Pfizer, Chesterfield, Mo.

Share

BEVERLY HILLS, Calif., April 10, 2019 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (OTCQX:TOMZ), a global company specializing in disinfection and decontamination essentials, announced today that SteraMist® implemented an iHP® Custom Build-In System to a newly constructed Pfizer facility in Chesterfield, MO. TOMI utilizes its premier Binary Ionization Technology® (BIT) platform through the manufacturing, licensing, servicing, and selling of its SteraMist® brand of products - a hydrogen peroxide-based mist and fog.

SteraMist is currently being used in multiple Pfizer facilities across the country, demonstrating a strong partnership, and committed to limiting the spread of dangerous pathogens. The Chesterfield facility, at approximately 295,000 square feet, houses their BioTherapeutics Pharmaceutical Sciences group, a building dedicated to R&D for potential new medicines.

SteraMist systems were installed in four (4) clean room cGMP suites, a total of twenty (20) ceiling-mounted SteraMist applicators connected to dual generator control cabinets, programmed to run one (1) or all applicators simultaneously. The system uses our fifty-five (55) gallon BIT solution drum and includes an E-stop button, custom-programmed HMI with clock times, H2O2 sensing, and PDF compliant result reports. This SteraMist iHP Custom Build-In System will be used on a daily basis to ensure total disinfection/decontamination.

Elissa Shane, TOMI COO, states, “TOMI is excited about our partnership with Pfizer as we continue to expand into their facilities. SteraMist is a perfect fit for pharmaceutical companies with the quick and high efficacy solution that iHP technology offers.”

TOMIEnvironmental Solutions, Inc.: Innovating for a safer world®

TOMI™ Environmental Solutions, Inc. (OTCQX:TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for indoor surface disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT solution utilizes a low percentage Hydrogen Peroxide as its only active ingredient to produce a hydroxyl radical ( . OH ion), referred to as ionized Hydrogen Peroxide (iHP). Represented by the SteraMist brand of products, iHP™ produces a germ-killing aerosol that works like a visual non-caustic gas.

TOMI products are designed to service a broad spectrum of commercial structures, including, but not limited to, hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, police and fire departments, and athletic facilities. TOMI products and services have also been used in single-family homes and multi-unit residences.

TOMI develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America and The Restoration Industry Association.

For additional information, please visit http://www.tomimist.com/ or contact us at info@tomimist.com.

Pfizer Inc.: Working together for a healthier world

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of healthcare products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer healthcare products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.pfizer.com. In addition, to learn more, please visit us on www.pfizer.com and follow us on Twitter at @Pfizer and @Pfizer_News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Certain written and oral statements made by us may constitute “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). Forward-looking statements are identified by such words and phrases as “we expect,” “expected to,” “estimates,” “estimated,” “current outlook,” “we look forward to,” “would equate to,” “projects,” “projections,” “projected to be,” “anticipates,” “anticipated,” “we believe,” “could be,” and other similar phrases. All statements addressing operating performance, events, or developments that we expect or anticipate will occur in the future, including statements relating to revenue growth, earnings, earnings-per-share growth, or similar projections, are forward-looking statements within the meaning of the Reform Act. They are forward-looking, and they should be evaluated in light of important risk factors that could cause our actual results to differ materially from our anticipated results. The information provided in this document is based upon the facts and circumstances known at this time. We undertake no obligation to update these forward-looking statements after the date of this release

INVESTOR RELATIONS CONTACT

Harold Paul
hpaul@tomimist.com

About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Conditions for sale of Riksbank certificates23.7.2019 09:30:00 CESTPress release

AUCTION DATE: JUL 23, 2019 START DATE: JUL 24, 2019 MATURITY DATE: JUL 31, 2019 NOMINAL AMOUNT: 413.0 BLN FIXED RATE: -0.25 % ALL MONETARY POLICY COUNTERPARTIES ARE INVITED TO SUBMIT BIDS TO THE RIKSBANK (08-6966970) BY 10.00 AM ON JUL 23 2019, AT THE LATEST. CONFIRMATION OF BIDS TO E-MAIL: RBCERT@riksbank.se THE LOWEST ACCEPTED BID VOLUME IS SEK 1 MLN. THE HIGHEST ACCEPTED BID VOLUME IS SEK 413.0 BLN. RESULT OF AUCTION WILL BE PUBLISHED AT 10.15 (CEST) ON JUL 23, 2019. COMPLETE TERMS AND CONDITIONS CAN BE RETRIEVED AT WWW.RIKSBANK.SE

Better Collective acquires US market leading sports betting brands; VegasInsider.com and ScoresandOdds.com23.7.2019 08:00:00 CESTPress release

Regulatory Release 21/2019 Better Collective has, through a wholly-owned US subsidiary, completed the acquisition of the assets of Florida based Vegasinsider.com and Scoresandodds.com for a total transaction price of 20 million USD to be paid in cash. Better Collective, the world’s leading sports betting affiliate, has acquired two of the leading sports betting websites in the United States (US). The brands have been market leading within sports betting information for more than 20 years and are expected to become market leading affiliate websites in those states where online sports betting is available. During the National Football League (NFL) 2018/2019 season, the two websites generated more than 15 million unique visits per month. Changing the business model With the aim of empowering sports bettors worldwide, Better Collective is adding the two websites to its portfolio of sites to educate and entertain users in the US as various states are beginning to regulate online sports bett

Vostok Emerging Finance buybacks during w.2923.7.2019 08:00:00 CESTPress release

Stockholm, July 23, 2019 (GLOBE NEWSWIRE) -- During the period July 15, 2019 until July 19, 2019, Vostok Emerging Finance Ltd (“VEF” or the “Company”) has repurchased in total 488,247 Swedish Depository Receipts (SDRs). The share buybacks have been made within the USD 5m buyback program announced by the Company on March 4, 2019. SDRs have been repurchased as follows during this period: Date Aggregated daily volume (number of SDRs) Weighted average SDR price per day (SEK) Total daily transaction value (SEK) July 15, 2019 95,700 2.47 235,962 July 16, 2019 97,500 2.45 239,125 July 17, 2019 104,000 2.47 256,835 July 18, 2019 106,000 2.45 259,811 July 19, 2019 85,047 2.48 210,715 All trades have been carried out on Nasdaq First North Stockholm by Pareto Securities AB on behalf of VEF. Following the above acquisitions, VEF holds 2,718,218 repurchased SDRs in the Company, and the total number of outstanding SDRs of the Company excluding repurchased SDRs is 658,777,777 and including repurchase

Vostok Emerging Finance buybacks during w.2923.7.2019 08:00:00 CESTPressemelding

Stockholm, July 23, 2019 (GLOBE NEWSWIRE) -- During the period July 15, 2019 until July 19, 2019, Vostok Emerging Finance Ltd (“VEF” or the “Company”) has repurchased in total 488,247 Swedish Depository Receipts (SDRs). The share buybacks have been made within the USD 5m buyback program announced by the Company on March 4, 2019. SDRs have been repurchased as follows during this period: Date Aggregated daily volume (number of SDRs) Weighted average SDR price per day (SEK) Total daily transaction value (SEK) July 15, 2019 95,700 2.47 235,962 July 16, 2019 97,500 2.45 239,125 July 17, 2019 104,000 2.47 256,835 July 18, 2019 106,000 2.45 259,811 July 19, 2019 85,047 2.48 210,715 All trades have been carried out on Nasdaq First North Stockholm by Pareto Securities AB on behalf of VEF. Following the above acquisitions, VEF holds 2,718,218 repurchased SDRs in the Company, and the total number of outstanding SDRs of the Company excluding repurchased SDRs is 658,777,777 and including repurchase

Idorsia announces financial results for the first half of 201923.7.2019 07:00:00 CESTPress release

Allschwil, Switzerland – July 23, 2019 Idorsia Ltd (SIX: IDIA) today announced its financial results for the first half of 2019. Key figures US GAAP operating expenses HY 2019 at CHF 252 million Non-GAAP operating expenses HY 2019 at CHF 234 million Unchanged guidance for 2019: US GAAP operating expenses of around CHF 570 million and non-GAAP operating expenses of around CHF 530 million (both measures exclude any potential milestone payments) Jean-Paul Clozel, MD and Chief Executive Officer, commented: “The first half of 2019 has been about running our studies and getting ready for the wave of results and news flow approaching soon. All departments are getting ready for the potential filing of our late stage assets. With the appointment of Simon Jose as Chief Commercial Officer the hiring of a core commercial team has begun, enabling the development of a commercial business plan. We expect to receive the first set of pivotal data in the first half of 2020.” Financial results US GAAP re